Target intelligence / Profile preview

Proline-rich protein 7, synaptic (PRR7)

Target
PRR7
Molecular classification
Other, Transmembrane adaptor protein
01

Overview

Proline-rich protein 7, synaptic (PRR7) is a transmembrane adaptor protein predominantly expressed in neurons and activated T cells[1][3][4][6]. In neurons, PRR7 localizes to the postsynaptic density and participates in synaptic modulation, particularly by inducing activity-dependent removal of excitatory synapses via exosomal secretion and inhibition of Wnt signaling[2]. PRR7 also serves as a synapse-to-nucleus signaling messenger, modulating NMDA receptor-mediated gene expression and neuronal survival in a c-Jun-dependent manner; its activity links synaptic activity to apoptosis, contributing to excitotoxic neuronal death relevant to neurodegenerative diseases[3][4][6]. In the immune system, PRR7 modulates T cell receptor signaling and apoptosis, fine-tuning immune activation and survival responses[3]. Despite its clear roles in neuronal and T-cell biology, there are currently no known marketed drugs or targeted therapeutics acting directly on PRR7, nor well-characterized use as a disease biomarker or safety concern beyond those related to apoptosis and neurotoxicity[2][3][4][5][6].

Other names
Proline-rich protein 7PRR7MGC10772Synaptic proline-rich membrane proteinProline rich 7 (synaptic)
02

Biological functions

Modulation of immune receptor signalingPositive regulation of apoptosisRegulation of synaptic densitySignal transductionRegulation of transcriptionSynapse eliminationInhibition of Wnt signalingPromotion of NMDA receptor-mediated excitotoxicity
03

Disease associations

Neurodegenerative diseaseApoptosis-related pathologiesPotential role in Toxic optic neuropathyMitochondrial complex II deficiency
04

Safety considerations

Potential for promoting excitotoxic neuronal deathApoptosis induction in T cells

Beyond the preview

Go deeper on Proline-rich protein 7, synaptic (PRR7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proline-rich protein 7, synaptic (PRR7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call